BackIntec Pharma Overview

Intec Pharma Research & Development

Research & Development expenses for NTEC.

Quarterly R&D Expenses

$2.16M
6.57% YoY

As of Mar 31, 2021

Annual R&D Expenses (TTM)

$6.87M
65.88% YoY

Trailing 12 months ending Mar 31, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)